WOBURN, MASSACHUSETTS, March 21, 2011 — BioProcess Technology Consultants, world leader in biopharmaceutical technical, strategic, and regulatory Chemistry, Manufacturing, and Controls (CMC) consulting, has named Julia Dishman Manager, Sales and Marketing.
Ms. Dishman will be responsible for helping to manage BioProcess Technology Consultants (BPTC) current client portfolio, develop and implement new marketing initiatives, provide customer service and follow-up, and assist the Company to realize its full potential as it expands internationally. Ms. Dishman also led BPTC’s recently completed rebranding initiative, assisting in the development of the Company’s new logo and launch of the Company’s newly redesigned website.
“Julie is a specialist in integrating industry and business knowledge into effective marketing solutions that help drive new business,” said Howard L. Levine, Ph.D., President of BPTC. “Her extensive experience working closely with senior management teams in the biotechnology industry to achieve business and sales objectives make her ideally suited for our team. Her fresh perspective and analytical approach will help us expand our consulting services globally,” added Dr. Levine.
Before joining BPTC, Ms. Dishman was an independent biotechnology business development consultant for both product and technology-based start-up companies, including BPTC. She was previously at Merrimack Pharmaceuticals, where she established the business development, market research, and public relations functions, helping the company raise $50 million in just over four years. She has also held positions in other industries in which she was responsible for bringing innovation into the organizations. She holds a B.A. in biology from the University of Virginia.
About BioProcess Technology Consultants, Inc.
Founded in 1994, BPTC is the recognized worldwide leader in biologics CMC consulting, providing a full range of technical, regulatory, and strategic assistance to biopharmaceutical and biotechnology companies in the development and commercialization of biopharmaceutical products. The company works with our clients to find solutions to the challenges of producing biopharmaceutical supply from clone to commercial. BPTC specializes in helping develop manufacturing processes and strategies and assists in developing product discovery and process development programs that enhance the overall value of client companies. BPTC also helps investors make informed decisions by providing technical and business evaluations of new products and technologies and product discovery, development, and commercialization plans of potential investments and existing portfolio companies. For more information about BPTC, visit http://www.bptc.com and follow the Company on Twitter at bptcGlobal or LinkedIn at http://www.linkedin.com/company/bioprocess-technology-consultants-inc.
